Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

pacific pharmaceuticals limited (part of mylan) - benzatropine mesilate 1 mg/ml - solution for injection - 2mg/2ml - active: benzatropine mesilate 1 mg/ml

Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

a. menarini new zealand pty ltd - benzatropine mesilate 1 mg/ml - solution for injection - 2 mg/2ml - active: benzatropine mesilate 1 mg/ml excipient: sodium chloride water for injection - cogentin is recommended for all forms of parkinsonism including arteriosclerotic, postencephalitic, idiopathic, as well as medicine-induced extrapyramidal disorders (except tardive dyskinesia). it can be effective at any stage of the disease, even when a patient has become bedridden. cogentin often is helpful in patients who have become unresponsive to other agents. cogentin is a powerful anticholinergic agent which is mainly effective in relieving tremor and rigidity. therapy is directed toward control of disturbing symptoms to permit the patient maximum integration of function with minimum discomfort. in non-medicine-induced parkinsonism, partial control of symptoms is usually achieved.

Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - benzatropine mesilate 2mg (2.04mg includes 2% overage) - tablet - 2 mg - active: benzatropine mesilate 2mg (2.04mg includes 2% overage) excipient: calcium hydrogen phosphate dihydrate lactose monohydrate magnesium stearate maize starch powdered cellulose

Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

a. menarini new zealand pty ltd - benzatropine mesilate 1 mg/ml - solution for injection - 2 mg/2ml - active: benzatropine mesilate 1 mg/ml excipient: hydrochloric acid purified water sodium chloride sodium hydroxide - benztropine omega is recommended for all forms of parkinsonism including arteriosclerotic, postencephalitic, idiopathic, as well as medicine-induced extrapyramidal disorders (except tardive dyskinesia). it can be effective at any stage of the disease, even when a patient has become bedridden. benztropine omega is often helpful in patients who have become unresponsive to other agents. benztropine omega is a powerful anticholinergic agent which is mainly effective in relieving tremor and rigidity. therapy is directed toward control of disturbing symptoms to permit the patient maximum integration of function with minimum discomfort. in non-medicine-induced parkinsonism, partial control of symptoms is usually achieved.

Wielka Brytania - angielski - MHRA (Medicines & Healthcare Products Regulatory Agency)

organon pharma (uk) ltd - benzatropine mesilate - oral tablet - 2mg

Wielka Brytania - angielski - MHRA (Medicines & Healthcare Products Regulatory Agency)

lundbeck pharmaceuticals ireland ltd - benzatropine mesilate - solution for injection - 1mg/1ml

Irlandia - angielski - HPRA (Health Products Regulatory Authority)

merck sharp and dohme limited - benzatropine mesilate - solution for injection - 1 mg milligram

Australia - angielski - Department of Health (Therapeutic Goods Administration)

a menarini australia pty ltd - benzatropine mesilate -

Irlandia - angielski - HPRA (Health Products Regulatory Authority)

merck sharp and dohme limited - benzatropine mesilate - tablets - 2 milligram

Singapur - angielski - HSA (Health Sciences Authority)

lundbeck singapore pte. ltd. - sterile aripiprazole monohydrate 416mg/vial equivalent to anhydrous aripiprazole - injection, powder, for suspension, extended release - sterile aripiprazole monohydrate 416mg/vial equivalent to anhydrous aripiprazole 400mg/vial